查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654443

病毒惰性市场规模、份额、趋势分析报告：按产品/服务、应用、最终用途、地区和细分市场进行预测，2025 年至 2030 年

Viral Inactivation Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents), By Application (Vaccines & Therapeutics), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

病毒惰性市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球病毒惰性市场规模预计到2030年将达到13.716亿美元，2025-2030年期间的复合年增长率为11.58%。

製药和生物製药公司数量的增加、FDA核准的药物数量的增加、生命科学产业的成长以及政府对新疗法和药物开发的资助增加是促进成长的一些主要因素。

随着公司数量、新药上市数量和新药发现数量的稳定增加，製药和生物製药行业正在经历显着的成长。随着全球疾病数量的增加，全球对新药物和改良治疗方法的需求也日益增长。主要企业增加对研发的投入，加上寻找治疗疾病的新治疗方法的需求，促进并加速了製药和生物製药公司的成长。

公司开发新药来增强健康效益。世界各地人们的生活方式改变，导致久坐不动的生活方式，这是需要药物和治疗方法治疗的慢性病增加的主要原因。根据 FDA 统计，2014 年核准了核准种新药，隔年核准了 45 种新药。这也有助于成长。

近年来，巨额资金涌入製药和生技产业。在私人公司为新药和新治疗方法的开发做出重大贡献的同时，政府对新治疗方法研发的支出也在增加。资金的增加也导致近年来 FDA核准数量的增加。所有这些因素都促进了病毒惰性市场的巨大成长。

病毒灭活市场报告重点

  • 套件和试剂产品部门占据市场主导地位，2024 年的收益占有率最大，为 57.37%。
  • 根据应用，由于对基因治疗和干细胞研究等研发应用的投资不断增加，疫苗和治疗部门将在 2024 年占据最大的收益占有率，为 34.41%。
  • 2024 年，製药和生物技术公司板块以 38.51% 的最大收益占有率引领市场。
  • 北美占据了最大的份额，因为那里拥有主要企业和先进的基础设施，以及抑制慢性病发病率的医疗改革。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章病毒灭活变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章：病毒灭活市场 - 按产品/服务进行的估计和趋势分析

  • 产品/服务细分仪表板
  • 全球病毒灭活市场产品与服务变化分析
  • 2018 年至 2030 年全球病毒灭活市场规模及趋势分析（依产品及服务）
  • 套件和试剂
  • 系统和配件
  • 服务

第 5 章：病毒灭活市场：按应用的估计和趋势分析

  • 应用程式细分仪表板
  • 全球病毒灭活市场应用变迁分析
  • 2018 年至 2030 年全球病毒灭活市场规模与趋势分析（按应用）
  • 疫苗和治疗
  • 干细胞产品
  • 血液和血液製品
  • 纸巾/纸巾产品
  • 细胞和基因治疗

第 6 章：病毒灭活市场 - 最终用途、估计与趋势分析

  • 最终用途细分仪表板
  • 全球病毒灭活市场最终用途变化分析
  • 2018 年至 2030 年全球病毒灭活市场规模及趋势分析（依最终用途）
  • 製药和生物技术公司
  • CRO
  • 学术研究所
  • 其他的

第 7 章：病毒灭活市场：区域、估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模、预测及趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与企业
  • 2024 年企业市场分析
  • 参与企业概况
    • Charles River Laboratories, Inc.
    • Clean Cells
    • Cytiva（Danaher Corporation）
    • Merck KGaA
    • Mettler Toledo
    • Parker Hannifin Corp
    • Rad Source Technologies Inc
    • Sartorius AG
    • Texcell SA
    • Vironova AB
Product Code: GVR-1-68038-998-2

Viral Inactivation Market Growth & Trends:

The global viral inactivation market size is estimated to reach USD 1,371.6 million by 2030, registering a CAGR of 11.58% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rise in the number of pharmaceutical and biopharmaceutical companies, increase in FDA drug approvals, growth of the life sciences industry, increase in government funding for novel therapies, and drug development are some of the major factors contributing to the growth.

Immense growth has been witnessed in the pharmaceutical and biopharmaceutical industry with a steady rise in the number of companies, drug launches, and new drug discoveries. With an increase in the number of diseases worldwide, the need for new & improved drugs and therapies has been witnessed on a global front. Increase in investment by top players in research and development coupled with the need to find new therapies for the treatment of diseases has contributed to immense growth of pharmaceutical and biopharmaceutical companies, thereby accelerating growth.

Newer drugs are being developed by companies to offer incremental health benefits. Changing lifestyle of people across the globe and adoption of sedentary living habits are primary reasons responsible for the increase in the number of chronic diseases that require drugs and therapies for treatment. According to the FDA, in the year 2014, 41 novel drugs were approved and 45 in the consequent year. This has also been contributing to growth.

Immense funding has been witnessed in the pharmaceutical and biotechnology industries in the recent years. It has been observed that private players are the major contributors for the development of new drugs and therapies, however, there has been increasing government spending on the research and development of new therapies. Increase in funding has also resulted in growth in number of FDA approvals over the recent years. All these factors have been contributing to the immense growth of the viral inactivation market.

Viral Inactivation Market Report Highlights:

  • The kits & reagents product segment led the market with the largest revenue share of 57.37% in 2024, attributed to the rise in biopharmaceutical and biotechnological companies worldwide.
  • By application, the vaccines and therapeutics segment held the largest revenue share of 34.41% in 2024, attributed to the rising investments in R&D applications such as gene therapy and stem cell research.
  • In 2024, the pharmaceutical and biotechnology companies segment led the market with the largest revenue share of 38.51%, attributed to the growth of pharmaceutical and biopharmaceutical companies.
  • North America accounted for the largest share owing to presence of dominant players and availability of sophisticated infrastructure along with healthcare reforms to curb the incidence of chronic diseases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Viral Inactivation Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand for Biopharmaceuticals
      • 3.2.1.2. Technological Advancements in Viral Inactivation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Viral Inactivation Techniques
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Viral Inactivation Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Viral Inactivation Market Product & Service Movement Analysis
  • 4.3. Global Viral Inactivation Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Systems & Accessories
    • 4.5.1. Systems & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Viral Inactivation Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Viral Inactivation Market Application Movement Analysis
  • 5.3. Global Viral Inactivation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Vaccines & Therapeutics
    • 5.4.1. Vaccines & Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Stem Cell Products
    • 5.5.1. Stem Cell Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Blood & Blood Products
    • 5.6.1. Blood & Blood Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tissue/ Tissue Products
    • 5.7.1. Tissue/ Tissue Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Cellular and Gene Therapy
    • 5.8.1. Cellular and Gene Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Viral Inactivation Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Viral Inactivation Market End Use Movement Analysis
  • 6.3. Global Viral Inactivation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnological Companies
    • 6.4.1. Pharmaceutical & Biotechnological Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. CROs
    • 6.5.1. CROs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Academic and Research Institutes
    • 6.6.1. Academic and Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Viral Inactivation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. South Korea Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant's Overview
    • 8.3.1. Charles River Laboratories, Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product/Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Clean Cells
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product/Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Cytiva (Danaher Corporation)
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product/Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Merck KGaA
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product/Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Mettler Toledo
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product/Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Parker Hannifin Corp
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product/Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Rad Source Technologies Inc
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product/Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Sartorius AG
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product/Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Texcell SA
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product/Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Vironova AB
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product/Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 6 Global viral inactivation market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 12 U.S. viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 15 Canada viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 18 Mexico viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 22 Europe viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 25 UK viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 28 Germany viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 31 France viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 32 France viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 Italy viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 37 Spain viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Denmark viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 40 Denmark viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 41 Denmark viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Sweden viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 43 Sweden viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 44 Sweden viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Norway viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Norway viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 47 Norway viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 53 Japan viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 56 China viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 57 China viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 59 India viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 60 India viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Australia viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Thailand viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 65 Thailand viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 66 Thailand viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 67 South Korea viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 68 South Korea viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 69 South Korea viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Latin America viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 73 Latin America viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 Brazil viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 76 Brazil viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 78 Argentina viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 85 South Africa viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 91 UAE viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 94 Kuwait viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new product & services
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Viral inactivation market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Viral inactivation market driver analysis
  • Fig. 12 Viral inactivation market restraint analysis
  • Fig. 13 Viral inactivation market: Porter's analysis
  • Fig. 14 Viral inactivation market: PESTEL analysis
  • Fig. 15 Viral inactivation market: Product & service outlook and key takeaways
  • Fig. 16 Viral inactivation market: Product & service market share analysis, 2024 - 2030
  • Fig. 17 Global viral inactivation market for kits and reagents, 2018 - 2030 (USD Million)
  • Fig. 18 Global viral inactivation market for systems & accessories, 2018 - 2030 (USD Million)
  • Fig. 19 Global viral inactivation market for services, 2018 - 2030 (USD Million)
  • Fig. 20 Viral inactivation market: Application outlook and key takeaways
  • Fig. 21 Viral inactivation market: Application market share analysis, 2024 - 2030
  • Fig. 22 Global viral inactivation market for vaccines and therapeutics, 2018 - 2030 (USD Million)
  • Fig. 23 Global viral inactivation market for stem cell products, 2018 - 2030 (USD Million)
  • Fig. 24 Global viral inactivation market for blood and blood products, 2018 - 2030 (USD Million)
  • Fig. 25 Global viral inactivation market for tissue/tissue products, 2018 - 2030 (USD Million)
  • Fig. 26 Global viral inactivation market for cellular and gene therapy, 2018 - 2030 (USD Million)
  • Fig. 27 Viral inactivation market: End use outlook and key takeaways
  • Fig. 28 Viral inactivation market: End use market share analysis, 2024 - 2030
  • Fig. 29 Global viral inactivation market for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 30 Global viral inactivation market for CROs, 2018 - 2030 (USD Million)
  • Fig. 31 Global viral inactivation market for academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 32 Global viral inactivation market for others, 2018 - 2030 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Canada viral inactivation, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Europe viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 UK viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 France viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Italy viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Spain viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Norway viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Asia-Pacific viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Japan viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 China viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 India viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Australia viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 MEA viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 UAE viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Key company categorization
  • Fig. 63 Company market positioning
  • Fig. 64 Market participant categorization
  • Fig. 65 Strategy framework